Drugs Made In America Acq... (DMAAU)
NASDAQ: DMAAU
· Real-Time Price · USD
10.50
-0.10 (-0.94%)
At close: Aug 19, 2025, 3:21 PM
10.50
0.00%
After-hours: Aug 19, 2025, 03:21 PM EDT
Company Description
Drugs Made In America Acquisition Corp. is a blank check company.
It is an exempt company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses.
The company was founded on May 23, 2024 and is headquartered in Fort Lauderdale, FL.
Drugs Made In America Acquisition Corp. Units
| Country | United States |
| IPO Date | Jan 27, 2025 |
| Industry | Financial - Conglomerates |
| Sector | Financial Services |
| Employees | 2 |
| CEO | Lynn Stockwell |
Contact Details
Address: 1 East Broward Boulevard, Suite 700 Fort Lauderdale, Florida United States | |
| Website | https://dmaacorp.com |
Stock Details
| Ticker Symbol | DMAAU |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0002028614 |
| CUSIP Number | n/a |
| ISIN Number | KYG2847J1206 |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Lynn Stockwell | Chief Executive Officer & Executive Chairman |
| Glenn Charles Worman | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2025 | 10-Q | Quarterly Report |
| Aug 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| May 20, 2025 | 10-Q | Quarterly Report |
| May 15, 2025 | SCHEDULE 13G | Filing |
| May 15, 2025 | NT 10-Q | Filing |
| May 15, 2025 | SCHEDULE 13G | Filing |
| May 15, 2025 | SCHEDULE 13G | Filing |
| May 14, 2025 | SCHEDULE 13G | Filing |
| May 14, 2025 | SCHEDULE 13G | Filing |
| Mar 31, 2025 | 10-K | Annual Report |